Pharma Reviews: Higher regulatory risk to affect drug cos' earnings

Indian generic pharmaceutical companies that export drugs to the US, therefore, find themselves in the throes of another regulatory crisis merely four ...
Read more: Higher regulatory risk to affect drug cos' earnings